Literature DB >> 1379591

A naturally occurring secreted form of fibroblast growth factor (FGF) receptor 1 binds basic FGF in preference over acidic FGF.

D S Duan1, S Werner, L T Williams.   

Abstract

Alternatively spliced variants of fibroblast growth factor receptor 1 mRNA are predicted to encode secreted forms and membrane-bound forms of receptors. The predicted amino acid sequences of these receptor variants differ in a portion of the extracellular region. In this study, we characterized the function of one of these splice variants which was predicted by its cDNA to be a secreted FGF receptor. We expressed this secreted form of the human FGFR1 (sFGFR1) in Chinese hamster ovary cells. The sFGFR1 protein oligomerized upon ligand binding. Surprisingly, the sFGFR1 preferentially bound basic FGF over acidic FGF. In cross-linking experiments, the sFGFR1 showed higher binding affinity for basic FGF (Kd approximately 30 nM) than for acidic FGF (Kd greater than 300 nM). These results suggest that this secreted form of FGF receptor has an unusual ligand binding specificity that may be important for its biological role in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379591

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae.

Authors:  Lin Feng; Wu-Xiang Liao; Quan Luo; Hong-Hai Zhang; Wen Wang; Jing Zheng; Dong-Bao Chen
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

2.  Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.

Authors:  Xiuqin Zhang; Omar A Ibrahimi; Shaun K Olsen; Hisashi Umemori; Moosa Mohammadi; David M Ornitz
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

Review 3.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

Review 4.  FGFR4: A promising therapeutic target for breast cancer and other solid tumors.

Authors:  Kevin M Levine; Kai Ding; Lyuqin Chen; Steffi Oesterreich
Journal:  Pharmacol Ther       Date:  2020-05-31       Impact factor: 12.310

5.  The mouse homolog of PKD1: sequence analysis and alternative splicing.

Authors:  C Löhning; U Nowicka; A M Frischauf
Journal:  Mamm Genome       Date:  1997-05       Impact factor: 2.957

6.  Identification of soluble forms of the fibroblast growth factor receptor in blood.

Authors:  A Hanneken; W Ying; N Ling; A Baird
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning.

Authors:  G Celli; W J LaRochelle; S Mackem; R Sharp; G Merlino
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

8.  Fibroblast growth factor (FGF) soluble receptor 1 acts as a natural inhibitor of FGF2 neurotrophic activity during retinal degeneration.

Authors:  X Guillonneau; F Régnier-Ricard; O Laplace; L Jonet; M Bryckaert; Y Courtois; F Mascarelli
Journal:  Mol Biol Cell       Date:  1998-10       Impact factor: 4.138

9.  Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer.

Authors:  Darren C Tomlinson; Margaret A Knowles
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

10.  Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation.

Authors:  S Werner; W Weinberg; X Liao; K G Peters; M Blessing; S H Yuspa; R L Weiner; L T Williams
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.